|
2016年9月，欧洲肿瘤内科学会（ESMO）官方期刊、牛津大学出版社旗下《肿瘤学年鉴》正式发表以色列舍巴医学中心、葡萄牙尚帕利莫临床中心、瑞士圣乔瓦尼医院、西班牙瓦尔德西布伦大学医院、英国剑桥大学、波兰格但斯克医科大学起草的欧洲肿瘤内科学会（ESMO）临床实践指南：乳腺癌易感基因（BRCA）突变携带者和其他乳腺卵巢遗传性癌症综合征的预防与筛查。 Ann Oncol. 2016 Sep;27(suppl 5):v103-v110. Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening. Paluch-Shimon S, Cardoso F, Sessa C, Balmana J, Cardoso MJ, Gilbert F, Senkus E; ESMO Guidelines Committee. Sheba Medical Center, Ramat Gan, Israel; Champalimaud Clinical Center, Lisbon, Portugal; Ospedale San Giovanni, Bellinzona, Switzerland; Vall d'Hebron University Hospital Institut d'Oncologia, Barcelona, Spain; University of Cambridge, Cambridge, UK; Medical University of Gdańsk, Gdańsk, Poland. The guidelines will focus on cancer prevention and screening among individuals known to harbour a pathogenic BRCA1/2 mutation. The presence of a BRCA1 or BRCA2 mutation accounts for the majority of hereditary breast and ovarian cancer syndromes. PMID: 27664246 DOI: 10.1093/annonc/mdw327 |
|
|
